Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise
    Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise
    • News

  • DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    • News

  • Stakk Secures T-Mobile Contract to Power Super App Expansion
    Stakk Secures T-Mobile Contract to Power Super App Expansion
    • News

  • Medibank Backs Emyria with Landmark Depression Care Deal
    Medibank Backs Emyria with Landmark Depression Care Deal
    • News

  • NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    • News

  • BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    • News

  • Harris Technology eyes profitability as refurbished tech sales surge
    Harris Technology eyes profitability as refurbished tech sales surge
    • News

  • QIC Fund Backs Ark Mines with $4.5m to Accelerate Sandy Mitchell Development
    • News

  • Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    • News

  • FBR’s tech could help reduce housing construction-related cost pressures
    FBR’s tech could help reduce housing construction-related cost pressures
    • News

Australian Government brings Micro-X’s Rover on board for X-ray imaging

  • In News
  • September 20, 2023
  • Alinda Gupta
Australian Government brings Micro-X’s Rover on board for X-ray imaging

Australian X-ray technology company Micro-X (ASX: MX1), known for its cold cathode X-ray technology used in health and security applications, has secured a Purchase Order worth $1.5 million from the Australian Government for its portable X-ray imaging tech Micro-X Rover systems. 

These Rover units are currently in stock and will go through final adjustments in Tonsley, Adelaide, before being delivered in early October 2023. The issuance of this Purchase Order is a result of the Micro-X sales team’s dedicated efforts.

Micro-X Chief Executive Officer, Kingsley Hall, commented, “We are thrilled that the Australian Government has placed an order for our Rover systems. The government’s purchase of our x-ray systems demonstrates the robustness and utility of our lightweight x-ray technology and goes to our core purpose of creating revolutionary imaging to better lives.” 

The Rover is a lightweight and portable X-ray machine called the Rover Mobile DR. It takes high-quality X-ray pictures for patients wherever they are—be it at home, in a hospital, or on a sports field. It’s light because it uses a special technology called NEX Technology that doesn’t need heavy materials like oil and lead, making it only about 100 kilograms heavy in total. This makes it much easier to move around without compromising on image quality.

In FY23, Micro-X reported a revenue uptick of 67% on FY22 to $15 million. Its loss reduced by 37% to $10.7 million, compared to a loss of over $17 million in FY22. This loss included investments in the development of a high-powered generator and associated X-ray tube and the Argus X-ray Camera, which are all but completed.

At the same time, its cash equivalents fell from $10.3 million to $5.2 million. Recognising its intense cash burn, the Company identified annualised cost savings of $2 million by tightening costs across its business, becoming effective on July 1, 2023.

Micro-X’s strategy going forward will include focusing on pushing its tech and exploring partnerships to capture the large addressable markets. In September 2022, Micro-X licensed its technology to X-ray tech component producer Varex to produce multi-beam emitters. The deal delivered a welcome $15 million cash injection to the Company.

The Company is set to receive $13 million in contracted revenue in FY24 for development work, once some milestones are fulfilled. These contracts are with the Australian Stroke Alliance for the CT Brain scanner, the U.S. Department of Homeland Security for the Miniature baggage scanner and Airport Self Service Portal, and Varex Imaging Corporation. Additionally, it anticipates turning most of its $6 million Rover inventory into positive cashflow, with minimal new expenses associated with these sales.

The current Australian Government contract is in line with the Company’s goals for Rover.

Hall added, “With this order, our re-energised sales team has delivered a total of $2.8 million in sales and orders of Mobile DR units this Quarter, which means we have progressed well in our previously announced strategy of increasing sales and converting our inventory into cash.” 

Micro-X has already shipped and invoiced $1.3 million of Mobile DR systems, including Rover Plus and Nano systems. With the addition of this Purchase Order for Rover systems, the total for this quarter reaches $2.8 million. This win was made possible thanks to existing inventory, aligning with the Company’s persistence to turn it into cash.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • asx mx1
  • kingsley hall
  • micro x
  • Rover Mobile
  • Varex Imaging
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.